Domača stran4530 • TYO
add
Hisamitsu Pharmaceutical Co Inc
Prejšnji trg. dan.
4.037,00 ¥
Dnevni razpon
4.011,00 ¥ - 4.066,00 ¥
Letni razpon
3.600,00 ¥ - 5.497,00 ¥
Tržna kapitalizacija
344,07 mrd. JPY
Povprečni obseg
115,68 tis.
Razm. P/E
20,96
Dividendna donosnost
2,10 %
Primarna borza
TYO
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(JPY) | maj 2024info | Sprememba L/L |
---|---|---|
Prihodek | 35,81 mrd. | 11,57 % |
Stroški poslovanja | 16,66 mrd. | 16,01 % |
Čisti dohodek | 4,79 mrd. | 18,25 % |
Čista dobičkovnost prihodkov | 13,37 | 5,94 % |
Earnings per share | — | — |
EBITDA | 5,44 mrd. | −2,80 % |
Efektivna davčna stopnja | 28,12 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(JPY) | maj 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 122,68 mrd. | −10,14 % |
Skupna sredstva | 338,84 mrd. | 5,83 % |
Skupne obveznosti | 71,98 mrd. | 22,92 % |
Celoten lastniški kapital | 266,86 mrd. | — |
Shares outstanding | 73,34 mio. | — |
Razmerje P/B | 1,12 | — |
Donosnost sredstev | 3,11 % | — |
Donosnost kapitala | 3,86 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(JPY) | maj 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 4,79 mrd. | 18,25 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Datum ustanovitve
1847
Sedež organizacije
Spletno mesto
Zaposleni
2.759